Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone for preschool wheeze
ACTRN12614000847617Phase 3Recruiting
- Sponsor
- Auckland District Health Board
- Start
- Aug 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in wheeze and acute respiratory illness (ARI) comparing Prednisolone with Placebo (2 arms). Primary endpoint: Change in PRAM score from baseline to 24 hours after first dose. Started Aug 2014; status: recruiting.
02
Drugs
prednisolone
03
Conditions
wheezeacute respiratory illness (ARI)
Beyond the preview
Go deeper on ACTRN12614000847617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000847617.